This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Formed in 2007 by the merger of the Chicago Mercantile Exchange (CME) and the Chicago Board of Trade (CBOT), CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. The Chicago Mercantile Exchange was originally formed as a non-profit organization in 1898, but was converted to a for-profit company in 2000. It became the first publicly traded financial exchange in the U.S. in Dec 2002. CBOT, established in 1848, is a leading futures and options exchange. In Apr 2005, CBOT converted into a for-profit stock-based holding company and for-profit membership exchange subsidiary.
Zacks Industry Outlook Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess
by Zacks Equity Research
Intercontinental Exchange, CME Group, Nasdaq, Cboe Global Markets and MarketAxess have been highlighted in this Industry Outlook article.
5 Stocks to Watch From the Prospering Securities and Exchanges Industry
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, NDAQ, CBOE and MKTX. However, compliance with regulations remains a challenge.
CME Stock Lags Industry YTD: What Should Investors Do Now?
by Tanuka De
A strong global presence, a compelling product portfolio, focus on over-the-counter clearing services and a solid capital position poise CME Group well for growth.
ICE Stock Outperforms Industry YTD: Time to Add it for Better Returns?
by Tanuka De
Investors who already hold Intercontinental Exchange stock should retain it, while new investors can wait for a better entry point given its growth prospects.
Nasdaq Stock Surges 43% YTD: What Should Be Investors' Approach Now?
by Tanuka De
NDAQ is set to grow on an increasing on-trading revenue base, impressive organic growth and investment in proprietary data supported by a solid capital position.
Top Stock Reports for Chevron, AstraZeneca & Arista Networks
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), AstraZeneca PLC (AZN) and Arista Networks, Inc. (ANET).
CME (CME) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Crypto-Centric Stocks to Gain as Bitcoin Looks Set to Hit $100,000
by Ritujay Ghosh
Stocks like NVDA, BLK, CME and ACN will gain from the ongoing crypto rally.
5 Crypto-Related Stocks With Upside as Bitcoin Hits All-Time High
by Ritujay Ghosh
Crypto-related stocks like NVDA, IBKR, BLK, ACN and CME are set to gain from Bitcoin's ongoing rally.
Cboe Global Q3 Earnings Top Estimates on Record Derivatives Volume
by Zacks Equity Research
CBOE's third-quarter results reflect record volumes across the company's derivatives platform.
Intercontinental's Q3 Earnings Match Estimates, Segment Results Solid
by Zacks Equity Research
ICE's third-quarter results reflect the strength of a balanced and diversified business as well as the benefits of the strategic investments it has made.
Top Stock Reports for Amazon.com, Johnson & Johnson and Boston Scientific
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Amazon.com, Inc. (AMZN), Johnson & Johnson (JNJ) and Boston Scientific Corporation (BSX), as well as a micro-cap stock Armanino Foods of Distinction, Inc. (AMNF).
Bitcoin Surpasses $71,000: Buy 4 Crypto Stocks With Growth Potential
by Ritujay Ghosh
Stocks like IBKR, CME, ACN and BLK are poised to benefit from the ongoing Bitcoin rally.
Nasdaq Tops Q3 Earnings Estimates, Tweaks Expense Guidance
by Zacks Equity Research
NDAQ's third-quarter results reflect broad-based growth across three divisions and another quarter of double-digit Solutions growth.
CME Group Q3 Earnings and Revenues Beat Estimates on Higher Volumes
by Zacks Equity Research
CME's third-quarter results reflect record trading volumes. Average daily volume increased in its six asset classes, with average daily volume up 20% in commodities and 28% in financial markets.
CME (CME) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for CME (CME) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
CME Group (CME) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 1.13% and 0.66%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Will Strong Commercial Lines Aid Hartford Financial's Q3 Earnings?
by Zacks Equity Research
Robust Commercial Lines, Personal Lines unit, coupled with rate hikes and strong investment income, are expected to have contributed to HIG's earnings beat.
Can CME Group Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
A diverse product portfolio, increased volatility and a strong market position are likely to have aided CME's performance in the third quarter.
Bitcoin on Track to Hit $70,000: 4 Crypto-Centric Stocks With Upside
by Ritujay Ghosh
Bitcoin-centric stocks like NVDA, CME, IBKR and ACN are poised to gain from the ongoing cryptocurrency rally.
Countdown to CME (CME) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of CME (CME) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
3 Bitcoin-Related Stocks to Gain From Crypto Rally
by Ritujay Ghosh
Bitcoin-centric stocks like Robinhood Markets (HOOD), NVIDIA (NVDA) and CME Group (CME) are poised to benefit from the ongoing rally.
Nasdaq (NDAQ) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Nasdaq (NDAQ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.